title: L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).
authors: Boston University School of Medicine, Vasculitis Center, Section of Rheumatology, 72, East Concord Street, E-533, Boston, MA 02118, USA. pmonach@bu.edu
authors: Paul A
authors: PA
authors: Monach
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007829:Laryngostenosis / Q000175:diagnosis / Q000188:drug therapy*; D008134:Long-Term Care; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069283:Rituximab; D055502:Secondary Prevention
chemical_list: D000893:Anti-Inflammatory Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D008727:Methotrexate